Lindsay McKay, PhD
Postdoctoral Associate (previously held)
Boston University Chobanian & Avedisian School of Medicine
Virology, Immunology & Microbiology



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Ye Z, Bonam SR, McKay LGA, Plante JA, Walker J, Zhao Y, Huang C, Chen J, Xu C, Li Y, Liu L, Harmon J, Gao S, Song D, Zhang Z, Plante KS, Griffiths A, Chen J, Hu H, Xu Q. Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. Proc Natl Acad Sci U S A. 2023 Dec 26; 120(52):e2311752120.View Related Profiles. PMID: 38134199; PMCID: PMC10756290; DOI: 10.1073/pnas.2311752120;
     
  2. Shrock EL, Timms RT, Kula T, Mena EL, West AP, Guo R, Lee IH, Cohen AA, McKay LGA, Bi C, Leng Y, Fujimura E, Horns F, Li M, Wesemann DR, Griffiths A, Gewurz BE, Bjorkman PJ, Elledge SJ. Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses. Science. 2023 Apr 07; 380(6640):eadc9498.View Related Profiles. PMID: 37023193; PMCID: PMC10273302; DOI: 10.1126/science.adc9498;
     
  3. Carter B, Huang P, Liu G, Liang Y, Lin PJC, Peng BH, McKay LGA, Dimitrakakis A, Hsu J, Tat V, Saenkham-Huntsinger P, Chen J, Kaseke C, Gaiha GD, Xu Q, Griffiths A, Tam YK, Tseng CK, Gifford DK. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Front Immunol. 2023; 14:1135815.View Related Profiles. PMID: 36969239; PMCID: PMC10033589; DOI: 10.3389/fimmu.2023.1135815;
     
  4. Carter B, Huang P, Liu G, Liang Y, Lin PJC, Peng BH, McKay LGA, Dimitrakakis A, Hsu J, Tat V, Saenkham-Huntsinger P, Chen J, Kaseke C, Gaiha GD, Xu Q, Griffiths A, Tam YK, Tseng CK, Gifford DK. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Front Immunol. 2023; 14:1135815.View Related Profiles. PMID: 36969239; PMCID: PMC10033589; DOI: 10.3389/fimmu.2023.1135815;
     
  5. Lim SY, Guo Z, Liu P, McKay LGA, Storm N, Griffiths A, Qu MD, Finberg RW, Somasundaran M, Wang JP. Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection. COVID. 2022 Nov; 2(11):1551-1563.View Related Profiles. PMID: 37274537; PMCID: PMC10238102; DOI: 10.3390/covid2110111;
     
  6. Nikitin PA, DiMuzio JM, Dowling JP, Patel NB, Bingaman-Steele JL, Heimbach BC, Henriquez N, Nicolescu C, Polley A, Sikorski EL, Howanski RJ, Nath M, Shukla H, Scheaffer SM, Finn JP, Liang LF, Smith T, Storm N, McKay LGA, Johnson RI, Malsick LE, Honko AN, Griffiths A, Diamond MS, Sarma P, Geising DH, Morin MJ, Robinson MK. IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2. Sci Immunol. 2022 Sep 09; 7(75):eabl9943.View Related Profiles. PMID: 35771946; PMCID: PMC9273042; DOI: 10.1126/sciimmunol.abl9943;
     
  7. Schwake C, McKay L, Griffiths A, Scartelli C, Flaumenhaft R, Chishti AH. BDA-410 inhibits SARS-CoV-2 main protease activity and viral replication in mammalian cells. J Cell Mol Med. 2022 Oct; 26(19):5095-5098.View Related Profiles. PMID: 36082511; PMCID: PMC9537889; DOI: 10.1111/jcmm.17442;
     
  8. Windsor IW, Tong P, Lavidor O, Moghaddam AS, McKay LGA, Gautam A, Chen Y, MacDonald EA, Yoo DK, Griffths A, Wesemann DR, Harrison SC. Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1. Sci Immunol. 2022 Aug 12; 7(74):eabo3425.View Related Profiles. PMID: 35536154; PMCID: PMC9097876; DOI: 10.1126/sciimmunol.abo3425;
     
  9. McKay LGA, Thomas J, Albalawi W, Fattaccioli A, Dieu M, Ruggiero A, McKeating JA, Ball JK, Tarr AW, Renard P, Pollakis G, Paxton WA. The HCV Envelope Glycoprotein Down-Modulates NF-?B Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway. Front Immunol. 2022; 13:831695. PMID: 35371105; PMCID: PMC8964954; DOI: 10.3389/fimmu.2022.831695;
     
  10. Ciencewicki JM, Herbert AS, Storm N, Josleyn NM, Huie KE, McKay LGA, Griffiths A, Dye JM, Willis T, Arora V. Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma. J Infect Dis. 2022 02 15; 225(4):733-740.View Related Profiles. PMID: 34448858
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 4 distinct years, with a maximum of 7 publications in 2022

YearPublications
20204
20214
20227
20233

Contact for Mentoring:

McKay's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (60) concept(s)
_
Co-Authors
See all (5) people
_
Similar People
See all (60) people
_
Same Department
Search Department